Bright Minds Biosciences DRUG 深 滬
交易中 10-10 11:32:56 美东时间
60.55
-0.860
-1.40%
華盛通- 最 高63.86
- 今 開61.70
- 成交量 3.27万股
- 最 低 59.89
- 昨 收 61.41
- 總市值 4.29亿
- 52周最高 63.86
- 市盈率 靜 --
- 換手率 0.46%
- 52周最低 23.175
- 委 比 34.23%
- 總股本 708.86万
- 歷史最高 79.02
- 量 比 1.27
- 振 幅 6.46%
- 歷史最低 0.93
- 每 手 1
- 風險率 9.15%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Mark Cuban Says AI Race Explains Musk, Zuckerberg and Dell Support for Trump
Mark Cuban says that the backing of President Donald Trump by Big Tech is more about staying ahead in the AI race than political alignment.
09-28 03:11
Large Patient Population Is Key Driver For Bright Minds' Growth
BTIG initiates coverage on Bright Minds Biosciences with a Buy rating, citing BMB‑101's potential and key Phase 2 data expected by the end of 2025
09-09 01:54
BTIG Initiates Coverage On Bright Minds Biosciences with Buy Rating, Announces Price Target of $72
BTIG analyst Thomas Shrader initiates coverage on Bright Minds Biosciences (NASDAQ:DRUG) with a Buy rating and announces Price Target of $72.
09-08 18:10
'Military To Start Testing Service Members For The Psychedelic Psilocin, Memo Shows' - Marijuana Moment
https://www.marijuanamoment.net/military-to-start-testing-service-members-for-the-psychedelic-psilocin-memo-shows/
08-29 02:16
American Regent® Launches Gvoke VialDx™ (glucagon injection)
First concentrated, ready-to-dilute liquid glucagon available for diagnostic procedures SHIRLEY, N.Y., Aug. 27, 2025 /PRNewswire/ -- American Regent, Inc.® is pleased to announce the commerc...
08-27 20:35
Bright Minds Biosciences to Present at Upcoming Conferences
Bright Minds Biosciences, a biotech company focused on developing selective 5-HT2 agonists for CNS disorders, will present at four upcoming conferences: the 36th International Epilepsy Congress in Lisbon, the Cantor Global Healthcare Conference, the H.C. Wainwright Global Investment Conference, and the Baird Global Healthcare Conference. Webcasts are available for the Cantor event. The company aims to address unmet medical needs in epilepsy, depr...
08-25 12:00
Jazz Pharmaceuticals to Host Modeyso™ (dordaviprone) Investor Webcast on August 27, 2025
DUBLIN, Aug. 20, 2025 /PRNewswire/ -- Jazz Pharmaceuticals plc (Nasdaq: JAZZ) will host an investor webcast on Wednesday, August 27, 2025, at 4:30 p.m. EDT / 9:30 p.m. IST to provide an over...
08-21 04:15
美股大行评级 | 美银证券：维持小鹏汽车"买入"评级，目标价从25美元升至26美元
今日重点评级关注：Canaccord Genuity：维持Cipher Mining"买入"评级，目标价从8美元升至9美元；美银证券：维持小鹏汽车"买入"评级，目标价从25美元升至26美元
08-20 10:48
HC Wainwright & Co. Reiterates Buy on Bright Minds Biosciences, Maintains $85 Price Target
HC Wainwright & Co. analyst Patrick R. Trucchio reiterates Bright Minds Biosciences (NASDAQ:DRUG) with a Buy and maintains $85 price target.
08-20 01:55
破局中药创新深水区：以岭药业五年五新药的战略跃迁｜我们这五年
编者按：春秋淬炼，凤凰涅��——这正是过去五载中国大健康产业的真实写照。 产业发展的每一步，皆铭刻着领航者的智慧与抉择。值此第五届华夏大健康产业发展大会启幕之际，《华夏时报》大健康团队推出 “我们这五年”系列专题报道，回溯跌宕征程，聆听核心亲历者的破局之声。
07-30 16:50
